T Cell Ig and Mucin Domain–Containing Protein 3 Is Recruited to the Immune Synapse, Disrupts Stable Synapse Formation, and Associates with Receptor Phosphatases
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
CD8+ CTLs are adept at killing virally infected cells and cancer cells and releasing cytokines (e.g., IFN-γ) to aid this response. However, during cancer and chronic viral infections, such as with HIV, this CTL response is progressively impaired due to a process called T cell exhaustion. Previous work has shown that the glycoprotein T cell Ig and mucin domain–containing protein 3 (Tim-3) plays a functional role in establishing T cell exhaustion. Tim-3 is highly upregulated on virus and tumor Ag-specific CD8+ T cells, and antagonizing Tim-3 helps restore function of CD8+ T cells. However, very little is known of how Tim-3 signals in CTLs. In this study, we assessed the role of Tim-3 at the immunological synapse as well as its interaction with proximal TCR signaling molecules in primary human CD8+ T cells. Tim-3 was found within CD8+ T cell lipid rafts at the immunological synapse. Blocking Tim-3 resulted in a significantly greater number of stable synapses being formed between Tim-3hiCD8+ T cells and target cells, suggesting that Tim-3 plays a functional role in synapse formation. Further, we confirmed that Tim-3 interacts with Lck, but not the phospho-active form of Lck. Finally, Tim-3 colocalizes with receptor phosphatases CD45 and CD148, an interaction that is enhanced in the presence of the Tim-3 ligand, galectin-9. Thus, Tim-3 interacts with multiple signaling molecules at the immunological synapse, and characterizing these interactions could aid in the development of therapeutics to restore Tim-3–mediated immune dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another inhibitory signaling mechanism discussed is the colocalization of TIM‐3 with CD45 and CD148 at the immunological synapse, where T cell function was suppressed [313].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [313]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · cited 1×
“However, these mechanisms also limit T cell responses to cancer Ags and chronic infection (1, 2).”
BackgroundMolecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114 · cited 1×
“Formation of an immunological synapse requires a T cell in conjugate with a target cell to provide a TCR stimulus and surface ligands/receptors on both cells to coordinate multiple costimulatory/inhibitory and immune accessory molecules (35, 36).”
BackgroundBlackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062 · cited 1×
“In addition, antagonizing these receptors with Abs or soluble fusion proteins results in partial rescue of effector function (6).”
BackgroundThe Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057 · cited 2×
“Tim-3 is carbohydrate dependent (17), and as such, galectin-9’s”
BackgroundWherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,610
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Sharpe, A. H., Wherry, E. J., Ahmed, R., & Freeman, G. J. (2007) · Nature Immunology · doi:10.1038/ni1443 · Cited by 1,528 · cited 1×
“However, these mechanisms also limit T cell responses to cancer Ags and chronic infection (1, 2).”
BackgroundMonney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,472
Yokosuka, T., Takamatsu, M., Kobayashi-Imanishi, W., Hashimoto-Tane, A., Azuma, M., & Saito, T. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112741 · Cited by 1,161 · cited 1×
“Similarly, PD-1 has also been found at the immunological synapse and negatively effects synapse stability, as defined by concentrated and centered CD3 at the T cell synapse (38).”
BackgroundCooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
Jin, H.-T., Anderson, A. C., Tan, W. G., West, E. E., Ha, S.-J., Araki, K., Freeman, G. J., Kuchroo, V. K., & Ahmed, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009731107 · Cited by 858
Jones, R. B., Ndhlovu, L. C., Barbour, J. D., Sheth, P. M., Jha, A. R., Long, B. R., Wong, J. C., Satkunarajah, M., Schweneker, M., Chapman, J. M., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081398 · Cited by 753 · cited 2×
“Soluble Tim-3 (sTim-3) was produced and purified as previously described (4) and biotinylated using the EZ-Link Sulfo-NHS-LC-Biotinylation Kit (Thermo Scientific, Rockford, IL).”
BackgroundMethodSelf-citationAnalysis of protein complexes using mass spectrometry
Gingras, A.-C., Gstaiger, M., Raught, B., & Aebersold, R. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2208 · Cited by 708 · cited 1×
“Although Tim-3 expression was induced via in vitro stimulation, no proteins were ever overexpressed, which can lead to artificial results and false positives, such as chaperones binding to overexpressed proteins (45).”
BackgroundPromotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells
Anderson, A. C., Anderson, D. E., Bregoli, L., Hastings, W. D., Kassam, N., Lei, C., Chandwaskar, R., Karman, J., Su, E. W., Hirashima, M., et al. (2007) · Science · doi:10.1126/science.1148536 · Cited by 701 · cited 8×
“In addition, these proteins have antagonistic Abs currently used in clinic or in phase III trials, respectively, for cancer treatment (48).”
BackgroundInfluentialFreeman, G. J., Casasnovas, J. M., Umetsu, D. T., & DeKruyff, R. H. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00903.x · Cited by 614
Ramsay, A. G., Johnson, A. J., Lee, A. M., Gorgün, G., Le Dieu, R., Blum, W., Byrd, J. C., & Gribben, J. G. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35017 · Cited by 600 · cited 2×
“In order to assess for immunological synapse formation, we used and modified a previous system (30) in which effector CD8 T cells are coincubated with B cell lines as APCs that are pulsed with SEB as the Ag.”
MethodTim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
Ndhlovu, L. C., Lopez-Vergès, S., Barbour, J. D., Jones, R. B., Jha, A. R., Long, B. R., Schoeffler, E. C., Fujita, T., Nixon, D. F., & Lanier, L. L. (2012) · Blood · doi:10.1182/blood-2011-11-392951 · Cited by 514
Self-citationSeki, M., Oomizu, S., Sakata, K.-M., Sakata, A., Arikawa, T., Watanabe, K., Ito, K., Takeshita, K., Niki, T., Saita, N., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.006 · Cited by 470
Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation
Nakayama, M., Akiba, H., Takeda, K., Kojima, Y., Hashiguchi, M., Azuma, M., Yagita, H., & Okumura, K. (2009) · Blood · doi:10.1182/blood-2008-10-185884 · Cited by 432
Golden-Mason, L., Palmer, B. E., Kassam, N., Townshend-Bulson, L., Livingston, S., McMahon, B. J., Castelblanco, N., Kuchroo, V., Gretch, D. R., & Rosen, H. R. (2009) · Journal of Virology · doi:10.1128/jvi.00639-09 · Cited by 431
Rangachari, M., Zhu, C., Sakuishi, K., Xiao, S., Karman, J., Chen, A., Angin, M., Wakeham, A., Greenfield, E. A., Sobel, R. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2871 · Cited by 394 · cited 6×
“p85 (the PI3K adaptor), and Lck (26, 27), further suggesting a role”
BackgroundResultInfluentialTIM‐3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines
Hastings, W. D., Anderson, D. E., Kassam, N., Koguchi, K., Greenfield, E. A., Kent, S. C., Zheng, X. X., Strom, T. B., Hafler, D. A., & Kuchroo, V. K. (2009) · European Journal of Immunology · doi:10.1002/eji.200939274 · Cited by 333 · cited 1×
“Blocking Tim-3 overnight on resting Tim3 CD8 T cells using the antagonistic Tim-3 mAb (10) significantly increased the number of stable synapses formed between T cells and their SEB-pulsed targets to 54(6 3.”
BackgroundNirschl, C. J., & Drake, C. G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1972 · Cited by 306
McMahan, R. H., Golden-Mason, L., Nishimura, M. I., McMahon, B. J., Kemper, M., Allen, T. M., Gretch, D. R., & Rosen, H. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43127 · Cited by 305
Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways
Lee, J., Su, E. W., Zhu, C., Hainline, S., Phuah, J., Moroco, J. A., Smithgall, T. E., Kuchroo, V. K., & Kane, L. P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05297-11 · Cited by 285 · cited 1×
“p85 (the PI3K adaptor), and Lck (26, 27), further suggesting a role”
BackgroundBi, S., Hong, P. W., Lee, B., & Baum, L. G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017954108 · Cited by 248 · cited 1×
“CD44 (18) and integrins (19), allowing association with Tim-3.”
BackgroundCao, E., Zang, X., Ramagopal, U. A., Mukhopadhaya, A., Fedorov, A., Fedorov, E., Zencheck, W. D., Lary, J. W., Cole, J. L., Deng, H., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.01.016 · Cited by 228
Ju, Y., Hou, N., Meng, J., Wang, X., Zhang, X., Zhao, D., Liu, Y., Zhu, F., Zhang, L., Sun, W., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.005 · Cited by 228
A highly conserved tyrosine of Tim‐3 is phosphorylated upon stimulation by its ligand galectin‐9
van de Weyer, P. S., Muehlfeit, M., Klose, C., Bonventre, J. V., Walz, G., & Kuehn, E. W. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.079 · Cited by 198 · cited 2×
“Although previous studies have shown that Tim-3 can be phosphorylated in epithelial cell lines and is enhanced by addition of galectin-9 (24, 25), it is still undetermined if this is the case in primary CD8 T cells.”
BackgroundResultDupré, L., Aiuti, A., Trifari, S., Martino, S., Saracco, P., Bordignon, C., & Roncarolo, M.-G. (2002) · Immunity · doi:10.1016/s1074-7613(02)00360-6 · Cited by 194 · cited 2×
“However, because TCR triggering results in the accumulation of lipid rafts at the synapse (34), it is likely that Tim-3 would accumulate.”
BackgroundMcNeill, L., Salmond, R. J., Cooper, J. C., Carret, C. K., Cassady-Cain, R. L., Roche-Molina, M., Tandon, P., Holmes, N., & Alexander, D. R. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.015 · Cited by 189 · cited 1×
“Interestingly, CD45 plays a dual role in positively and negatively regulating Lck, depending on the expression level of CD45 (42).”
BackgroundBaitsch, L., Legat, A., Barba, L., Fuertes Marraco, S. A., Rivals, J.-P., Baumgaertner, P., Christiansen-Jucht, C., Bouzourene, H., Rimoldi, D., Pircher, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030852 · Cited by 184
Hermiston, M. L., Zikherman, J., & Zhu, J. W. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00752.x · Cited by 170 · cited 1×
“Use of primary CD8 T cells provides an intact TCR signaling platform, including presence of proximal signaling molecules, regulation via lipid raft dynamics, and presence of receptor phosphatases that are essential for the initiation and final dampening of TCR signaling (44, 46, 47).”
BackgroundGalectin-9 Inhibits CD44–Hyaluronan Interaction and Suppresses a Murine Model of Allergic Asthma
Katoh, S., Ishii, N., Nobumoto, A., Takeshita, K., Dai, S.-Y., Shinonaga, R., Niki, T., Nishi, N., Tominaga, A., Yamauchi, A., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1243oc · Cited by 166 · cited 2×
“CD44 (18) and integrins (19), allowing association with Tim-3.”
BackgroundWu, W., Shi, Y., Li, S., Zhang, Y., Liu, Y., Wu, Y., & Chen, Z. (2012) · European Journal of Immunology · doi:10.1002/eji.201141852 · Cited by 158
Lipid rafts in T cell receptor signalling (Review)
Kabouridis, P. S. (2006) · Molecular Membrane Biology · doi:10.1080/09687860500453673 · Cited by 142 · cited 1×
“TCR signaling predominantly occurs within distinct membrane microdomains called lipid rafts (31, 32).”
Immunological synapse and microclusters: the site for recognition and activation of T cells
Saito, T., & Yokosuka, T. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.014 · Cited by 124 · cited 1×
“Formation of an immunological synapse requires a T cell in conjugate with a target cell to provide a TCR stimulus and surface ligands/receptors on both cells to coordinate multiple costimulatory/inhibitory and immune accessory molecules (35, 36).”
BackgroundLin, J., & Weiss, A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303040 · Cited by 106 · cited 2×
“synapse (33, 44), concurrent ligation of these receptor phosphatases with Tim-3 via galectin-9 could enhance the presence of these phosphatases at the synapse, resulting in negative regulation of Lck as well as dampening of TCR signaling.”
BackgroundVali, B., Jones, R. B., Sakhdari, A., Sheth, P. M., Clayton, K., Yue, F., Gyenes, G. T., Wong, D., Klein, M. B., Saeed, S., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040340 · Cited by 105
Self-citationTim-3 Negatively Regulates Cytotoxicity in Exhausted CD8+ T Cells in HIV Infection
Sakhdari, A., Mujib, S., Vali, B., Yue, F. Y., MacParland, S. A., Clayton, K., Jones, R. B., Liu, J., Lee, E. Y., Benko, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040146 · Cited by 104
Self-citationMujib, S., Jones, R. B., Lo, C., Aidarus, N., Clayton, K., Sakhdari, A., Benko, E., Kovacs, C., & Ostrowski, M. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102609 · Cited by 101 · cited 1×
“8; BioLegend) with 50 U/ml rIL-2 (National Institutes of Health, Bethesda, MD) for 5–7 d to upregulate Tim-3 (29).”
Self-citationZikherman, J., Jenne, C., Watson, S., Doan, K., Raschke, W., Goodnow, C. C., & Weiss, A. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.006 · Cited by 90 · cited 1×
“Use of primary CD8 T cells provides an intact TCR signaling platform, including presence of proximal signaling molecules, regulation via lipid raft dynamics, and presence of receptor phosphatases that are essential for the initiation and final dampening of TCR signaling (44, 46, 47).”
BackgroundTIM-3 Does Not Act as a Receptor for Galectin-9
Leitner, J., Rieger, A., Pickl, W. F., Zlabinger, G., Grabmeier-Pfistershammer, K., & Steinberger, P. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003253 · Cited by 90 · cited 1×
“Despite a recent study that claimed human Tim-3 was not the receptor for human galectin-9 (43), we confirmed that galectin-9 was the physiological ligand for Tim-3 using two different biochemical assays.”
MethodLi, D., Molldrem, J. J., & Ma, Q. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.002865 · Cited by 74 · cited 1×
“In addition, to increase the stringency of our approach, we included phospho-ERK signaling, which results from an integration of signals from both the TCR and activated LFA-1 (39), as an additional parameter to define a stable synapse, which is capable of eliciting downstream signaling.”
MethodInitiation of TCR Phosphorylation and Signal Transduction
Gascoigne, N. R. J., Casas, J., Brzostek, J., & Rybakin, V. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00072 · Cited by 54 · cited 1×
“CD8 binds to the MHC, increasing the stability of the MHC–TCR complex (40), sustaining proximal signaling and initiation of downstream signaling.”
BackgroundLck, Membrane Microdomains, and TCR Triggering Machinery: Defining the New Rules of Engagement
Filipp, D., Ballek, O., & Manning, J. E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00155 · Cited by 54 · cited 5×
“synapse (33, 44), concurrent ligation of these receptor phosphatases with Tim-3 via galectin-9 could enhance the presence of these phosphatases at the synapse, resulting in negative regulation of Lck as well as dampening of TCR signaling.”
BackgroundInfluentialDysregulation of TIM-3–Galectin-9 Pathway in the Cystic Fibrosis Airways
Vega-Carrascal, I., Reeves, E. P., Niki, T., Arikawa, T., McNally, P., O'Neill, S. J., Hirashima, M., & McElvaney, N. G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003187 · Cited by 42
A New Type of Membrane Raft-Like Microdomains and Their Possible Involvement in TCR Signaling
Otáhal, P., Angelisová, P., Hrdinka, M., Brdička, T., Novák, P., Drbal, K., & Hořejší, V. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902075 · Cited by 36 · cited 1×
“TCR signaling predominantly occurs within distinct membrane microdomains called lipid rafts (31, 32).”
BackgroundLee, M. J., Woo, M.-Y., Chwae, Y., Kwon, M., Kim, K. H., & Park, S. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.01.012 · Cited by 32
Role of LAT in the Granule-Mediated Cytotoxicity of CD8 T Cells
Ou-Yang, C.-W., Zhu, M., Fuller, D. M., Sullivan, S. A., Chuck, M. I., Ogden, S. C., Li, Q.-J., & Zhang, W. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00356-12 · Cited by 23 · cited 1×
“naling, such as Lck phosphorylation and subsequent downstream signaling to linker for activation of T cells, is required for stable synapse formation (41), further providing evidence that Tim-3 is involved in TCR proximal signaling.”
Background
Cited by
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Immune checkpoint signaling and cancer immunotherapy
He, X., & Xu, C. (2020) · Cell Research · doi:10.1038/s41422-020-0343-4 · Cited by 1,371
“Another work showed that TIM3 interacted with multiple proximal TCR signaling molecules in the immune synapse, with TIM3 blockade enhancing stable synapse formation between TIM3 CD8 T cells and target cells.(90) TIM3 contains five conserved tyrosine residues in its cytoplasmic domain, among which Y265 (Y256 in mouse)…”
BackgroundTIM3 comes of age as an inhibitory receptor
Wolf, Y., Anderson, A. C., & Kuchroo, V. K. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0224-6 · Cited by 959
Tim‐3 and its role in regulating anti‐tumor immunity
Das, M., Zhu, C., & Kuchroo, V. K. (2017) · Immunological Reviews · doi:10.1111/imr.12520 · Cited by 856
Tim-3 finds its place in the cancer immunotherapy landscape
Acharya, N., Sabatos-Peyton, C., & Anderson, A. C. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000911 · Cited by 394
Metadata
- Authors
- Clayton, K. L., Haaland, M. S., Douglas-Vail, M. B., Mujib, S., Chew, G. M., Ndhlovu, L. C., & Ostrowski, M. A.
- Affiliations
- University of Toronto (CA)
- University of Hawaiʻi at Mānoa (US)
- St. Michael's Hospital (CA)
- Corresponding author
- Ostrowski, Mario A
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01
- Volume
- 192
- Issue
- 2
- Pages
- 782-791
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4214929
- OpenAlex
- W2121603793
- Cited by
- 134
- References
- 48
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 14 · 2023: 15 · 2022: 8 · 2021: 19 · 2020: 13 · 2019: 3 · 2018: 8 · 2017: 7 · 2016: 4 · 2015: 4 · 2014: 8
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Canadian Institutes of Health Research
- National Institute of Allergy and Infectious Diseases (R56AI083112, P30AI027763)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- TIM-3, immunological synapse, CD8+ T cells, T cell exhaustion, galectin-9, Lck, CD45, CD148, lipid rafts, T cell signaling
- MeSH terms
- Hepatitis A Virus Cellular Receptor 2, Humans, Membrane Proteins, Phosphoric Monoester Hydrolases, Synapses, Signal Transduction, HIV Infections, Leukocyte Common Antigens, CD8-Positive T-Lymphocytes, Lymphocyte Specific Protein Tyrosine Kinase p56(lck), Galectins, Receptor-Like Protein Tyrosine Phosphatases, Class 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.